Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Presented for research literature review only de ARGUMOSA JA et al
Hypoglycaemia risk is a key concern when GLP-1-based agents are combined with insulin or insulin secretagogues such as sulphonylureas
Expected Results: Timeline and Benchmarks Setting realistic expectations requires understanding how each compound contributes over time
The intensity and type of side effects vary widely based on individual metabolism, starting dose, and gastrointestinal sensitivity
US$ 27.35
US$ 25.77
US$ 28.59
US$ 26.57
US$ 27.13
US$ 23.06
US$ 21.82
